Name: Return on Assets (ROA)

Definition: ROA shows how efficiently the company turns everything it owns — its entire asset base — into net profit after all costs and taxes. A higher ROA means the business squeezes more profit from its assets. Lower ROA might reflect poor asset utilization or heavy reliance on expensive financing.

Interpretation:
• In '2021', IMTX's return on assets was -53.4%, representing returns generated from total assets. Industry average for Biotechnology: Biological Products (No Diagnostic Substances) in '2021' stood at -44.1%.
• In '2022', IMTX's return on assets was 9.5%, representing returns generated from total assets. The increase since '2021' reflects strengthening financial performance. Industry average for Biotechnology: Biological Products (No Diagnostic Substances) in '2022' stood at -62.8%. Industry average declined by 18.7% from previous year.
• In '2023', IMTX's return on assets was -20.6%, representing returns generated from total assets. The decline from '2022' may indicate some operational or financial challenges. Industry average for Biotechnology: Biological Products (No Diagnostic Substances) in '2023' stood at -61.6%. Industry average increased by 1.2% compared to previous year.
• In '2024', IMTX's return on assets was 2.5%, representing returns generated from total assets. The increase since '2023' reflects strengthening financial performance. Industry average for Biotechnology: Biological Products (No Diagnostic Substances) in '2024' stood at -61.2%. Industry average increased by 0.4% compared to previous year.
Overall, IMTX's return on assets has been volatile but showed an upward trend over the past 4 years.

Formula: ROA = Net Income / Total Assets

Good Range: Commonly 5%-15%.